TRIO ART-OPTIMISATION

TRIO: LONG-TERM EVALUATION OF RISK-BENEFIT FOR DOLUTEGRAVIR IN THREE RANDOMISED TRIALS
ADVANCE, DolPHIN 2 and NAMSAL-ANRS 12313 trials

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

Pooled data analysis from three large-scale clinical trials reveal long-term effects of dolutegravir-based treatment regimens on people living with HIV https://t.co/eEzgwonujc

[Unitaid @UNITAID]

Earlier in May, Unitaid announced new estimates projecting US$7 billion in savings to health systems by 2030, resulting from the rapid and widescale implementation of a groundbreaking treatment for HIV, dolutegravir.

Find out more: https://t.co/4s9PVjnQhk

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

@FrancoisVenter3 is debating if choice is the most critical factor in the future of treatment optimization #IAS2023

[DolPHIN 2 @UoLDolphin2]

Chief investigator Prof Saye Khoo is participating in Enabling the ecosystem to accelerate HIV treatment optimization: Reflecting on what’s worked, what hasn’t, and looking ahead at #IAS2023 discussing the successes in DolPHIN2 and TRIO

[Francois Venter @FrancoisVenter3]

Nkuli Mashabane, clinical trialist extraordinaire, taking us through the ADVANCE trial planning. @INTERESTconf

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

Unitaid’s ART optimization portfolio ensures end-to-end approach to tackle access barriers to new optimal ARV’s- Pamela Nawaggi from Unitaid @INTERESTconf @UNITAID @ezintsha @LivUni @namsal

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

The @UNITAID funded ART Optimization portfolio has produced great lessons on conducting clinical trials in Africa. Join us @INTERESTconf on 11 May at 18:00. @aidsmap @ezintsha @agenceANRS @LivUni #INTEREST2023 #HIV #Mozambique

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

Join us on Thursday 11 May at this year’s #INTEREST for our special session.

@FrancoisVenter3 @ezintsha @agenceANRS @UNITAID @LivUni

[HIV Drug Interactions @hivinteractions]

💊 New comedications added to the HIV site
Dronedarone (Antiarrhythmics)
Apalutamide (Cancer therapies)
Bempedoic acid, Icosapent ethyl, Omega-3 fatty acids (Lipid Lowering Agents)
Omega-3 fatty acids [in multivitamins] (Herbals/Supplements/Vitamins)
Tirzepatide (Anti-diabetics)

[Adeeba Kamarulzaman @ProfAdeeba]

The #HIV response requires a bold champion to help avert millions of needlessly lost lives.

I cordially invite you, @JustinTrudeau, to address the global HIV community at the #AIDS2022 closing ceremony to outline your vision for the HIV response at home and around the world.

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

People watts to learn

[Catriona Waitt @CatrionaWaitt]

#HappeningNow #AIDS2022 @AIDS_conference @TRIO_ARToptim @UoLDolphin2 @agenceANRS session in the Global Village. Come and hear from study participants and team members.

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

HAPPENING NOW
At Globalvillage. @TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

Thank you 🙏 very much to joined @TRIO_ARToptim during the satellite symposium @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

TRIO SYMPOSIUM
Closing remarks!!
,@TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

TRIO SYMPOSIUM
presentation going on!!!
Picture
@TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

TRIO SYMPOSIUM
Live!ĺĺ
Transition from clinical trial to national programme
@TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

TRIO SYMPOSIUM
Move to session 2: Community engagement
@TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

Picture @TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

LIVE ! TRIO Symposium
Treatment Optimisation: lessons from TRIO- ADVANCE, DOLPHIN2 AND NAMSAL- ANRS-12313 trial funded by UNITAID @TRIO_ARToptim @AIDS_conference @UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022

[TRIO ART-OPTIMISATION @TRIO_ARToptim]

HAPPENING NOW!!! @TRIO_ARToptim satellite symposium @AIDS_conference -room 517c/channel 4
@UNITAID @WHO @ezintsha @LivUni @agenceANRS @SiteAnrsCamroun @UoLDolphin2 @transvihmi #AIDS2022